Gliflozin: A Revolution in Heart Failure Treatment
Gliflozins, initially developed as diabetes drugs, have proven to be one of the greatest revolutions in diabetes care.
Patients without Mavacamten, no reimbursement
Mavacamten is an innovative drug that represents a concrete and immediate hope and an alternative to surgery for many patients ...
An international network against rare diseases
Be careful not to consider rare diseases as marginal. This is the risk that, according to Professor Giuseppe Limongelli, director of the Diseases Unit ...
Challenges for Cardiomyopathy Patients as They Transition to Adulthood
In 2022, the University of Pisa, led by Professor Martina Smorti, launched a research study...
Innovative surgical therapies for all patients
The course on Hypertrophic Obstructive Cardiomyopathy, organized by AICARM Aps, saw the participation of the best Italian specialists. Surgery ...
Anticoagulants and antiaggregants in pregnancy
In women with different types of cardiomyopathy and taking antiplatelet or anticoagulant drugs, there is a risk of maternal hemorrhages ...
My experience in San Diego where new therapies are explored
The first gene therapy for an inherited heart disease has been developed at the University of California San Diego (UCSD): the ...
Myectomy and mitral plastic surgery, the most effective therapy for young patients
The Hypertrophic Obstructive Cardiomyopathy Treatment Course is designed to present the impact of obstruction on quality of life and ...
Gene therapy for hypertrophic cardiomyopathy, what's new
Cardiomyopathies are a group of diseases that affect the heart muscle, causing impaired heart muscle function and also ...
Risk assessment of beta-blockers in pregnant women with cardiomyopathy
Therapy during pregnancy involves the use of various drugs including the beta-blocker family, used in the treatment of some ...
